Inhibitors of Mammalian Target of Rapamycin
Publisher
Wiley-Blackwell
Reference161 articles.
1. Rapamycin: a novel immunosuppressive macrolide;Sehgal;Med Res Rev,1994
2. Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer;Raymond;J Clin Oncol,2004
3. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP;Choi;Science,1996
4. A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies;Rizzieri;Clin Cancer Res,2008
5. Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression;Chen;J Cardiovasc Pharmacol,2007